Recombinant multi-species ALDOA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ALDOA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the class I fructose-bisphosphate aldolase protein family. The encoded protein is a glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Three aldolase isozymes (A, B, and C), encoded by three different genes, are differentially expressed during development. Mutations in this gene have been associated with Glycogen Storage Disease XII, an autosomal recessive disorder associated with hemolytic anemia. Disruption of this gene also plays a role in the progression of multiple types of cancers. Related pseudogenes have been identified on chromosomes 3 and 10. [provided by RefSeq, Sep 2017]
The Alternative Names of target: ALDA,ALDOA,Aldo-1,Aldo1,Aldoa,Fructose-bisphosphate aldolase A,GSD12,HEL-S-87p,Lung cancer antigen NY-LU-1,Muscle-type aldolase,RNALDOG5

Target products collectionGo to ALDOA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6566-Ag-1/ GM-Tg-hg-IP6566-Ag-2 Human ALDOA protein Human
GM-Tg-rg-IP6566-Ag-1/ GM-Tg-rg-IP6566-Ag-2 Rat ALDOA protein Rat
GM-Tg-mg-IP6566-Ag-1/ GM-Tg-mg-IP6566-Ag-2 Mouse ALDOA protein Mouse
GM-Tg-cynog-IP6566-Ag-1/ GM-Tg-cynog-IP6566-Ag-2 Cynomolgus/Rhesus macaque ALDOA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6566-Ag-1/ GM-Tg-felg-IP6566-Ag-2 Feline ALDOA protein Feline
GM-Tg-cang-IP6566-Ag-1/ GM-Tg-cang-IP6566-Ag-2 Canine ALDOA protein Canine
GM-Tg-bovg-IP6566-Ag-1/ GM-Tg-bovg-IP6566-Ag-2 Bovine ALDOA protein Bovine
GM-Tg-equg-IP6566-Ag-1/ GM-Tg-equg-IP6566-Ag-2 Equine ALDOA protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6566-Ag-1/ GM-Tg-hg-IP6566-Ag-2; GM-Tg-rg-IP6566-Ag-1/ GM-Tg-rg-IP6566-Ag-2;
GM-Tg-mg-IP6566-Ag-1/ GM-Tg-mg-IP6566-Ag-2; GM-Tg-cynog-IP6566-Ag-1/ GM-Tg-cynog-IP6566-Ag-2;
GM-Tg-felg-IP6566-Ag-1/ GM-Tg-felg-IP6566-Ag-2; GM-Tg-cang-IP6566-Ag-1/ GM-Tg-cang-IP6566-Ag-2;
GM-Tg-bovg-IP6566-Ag-1/ GM-Tg-bovg-IP6566-Ag-2; GM-Tg-equg-IP6566-Ag-1/ GM-Tg-equg-IP6566-Ag-2
Products Name ALDOA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ALDOA
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ALDOA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.